Latest Regulatory Milestones News

American West Metals is finalising its Pre-Feasibility Study for the Storm Copper Project in Nunavut, advancing permitting and exploration along a 110km copper belt, backed by secured development funding.

AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.

AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.

Elementos Limited has secured a key regulatory milestone as the Regional Government of Andalucía grants its Oropesa Tin Project Overriding Public Interest status, easing the path for critical water licensing and advancing permitting certainty.

Sky Metals has reported new shallow, wide, high-grade tin-tungsten-silver drill intercepts at its Tallebung Project, expanding the deposit ahead of an imminent Mineral Resource Estimate and Pre-Feasibility Study.

The a2 Milk Company has clinched final Chinese regulatory approval to rebrand infant formula products under its flagship a2™ label, completing a pivotal acquisition step. The company plans to launch these products later in 2026 and is poised to declare a $300 million special dividend.

St Barbara has passed a key regulatory milestone for its 15-Mile Processing Hub in Nova Scotia, submitting the Initial Project Description and triggering a coordinated federal-provincial review. The project features a redesigned footprint that cuts environmental disturbance by up to 55% and consolidates processing to a single hub, promising strong economic benefits and community engagement.

Finder Energy has issued 12 million shares at 50 cents each, raising $6 million from Amplus Energy and Longreach Capital following shareholder approval.

Island Pharmaceuticals has won a key regulatory boost as the US FDA granted Orphan Drug Designation to Galidesivir for post-exposure prophylaxis of Marburg virus disease, enhancing its commercial and development prospects.

Sweden's Parliament has amended legislation to remove uranium mining from nuclear facility regulations, simplifying permits and strengthening Aura Energy's prospects for its Häggån uranium deposit.

CLINUVEL Pharmaceuticals has lodged its Form 20-F with the U.S. SEC, seeking to elevate its American Depository Receipt program to a Nasdaq-listed American Depository Share, aiming to boost visibility and liquidity without raising capital.

Vault Minerals is on track to meet FY26 production targets with a strong focus on expanding its King of the Hills operation and progressing a merger with Regis Resources, positioning itself as a senior gold producer.